https://www.vectanspharma.com/join-us/
Join us - Vectans Pharma
May 29, 2026 - Loramyc® 50 mg, is a muco‐adhesive buccal tablets indicated for the treatment of oropharyngeal candidiasis in immunocompromised patients
join usvectanspharma
https://www.vectanspharma.com/nomination-of-francois-boutignon-as-chief-innovation-and-technology-officer/
Press release Chief Innovation and Technology Officer - Vectans Pharma
Mar 24, 2022 - Vectans Pharma is pleased to annouce the nomination of François Boutignon as Chief Innovation and Technology Officer.
innovation and technologypress releasechiefofficervectans